RISK FACTORS AND EARLY DETECTION STRATEGIES IN BREAST NEOPLASMS: A 5-YEAR SYSTEMATIC REVIEW
DOI:
https://doi.org/10.37547/Keywords:
Breast neoplasms, risk factors, early detection, screening strategies, mammography, magnetic resonance imaging, digital breast tomosynthesis, BRCA1, BRCA2, risk stratification.Abstract
Breast neoplasms remain a major global health concern and represent one of the leading causes of cancer-related morbidity and mortality among women. Understanding both modifiable and non-modifiable risk factors, together with implementing effective early detection strategies, is essential for improving prognosis and reducing disease burden.
Downloads
References
1.Gao, Y., Moy, L., & Heller, S. L. (2021). Digital breast tomosynthesis: Update on technology, evidence, and clinical practice. Radiologic Clinics of North America, 59(1), 1–15.
2.Hernández, M. L., Oseni, T. O., & Pisano, E. D. (2020). Abbreviated MRI for breast cancer screening: Current evidence and future directions. Academic Radiology, 27(2), 179–187.
3.Lukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021). Breast cancer—Epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Cancers, 13(17), 4287.
4.Luker, G. D., et al. (2020). MRI screening reduces interval breast cancer in women with dense breasts. Journal of Clinical Oncology, 38(15), 1675–1685.
5.Petrucelli, N., Daly, M. B., & Feldman, G. L. (2023). BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In GeneReviews®. University of Washington, Seattle.
6.Ren, W., et al. (2022). Global guidelines for breast cancer screening: A systematic review. Journal of Global Oncology, 8, e2100423.
7.Zheng, Y., et al. (2022). Risk-adapted breast cancer screening strategies based on individual risk profiles: Current evidence and future perspectives. Frontiers in Oncology, 12, 965060.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
